Thousands of formulas in the library: what the number gives a buyer and what it does not

An accumulated formula library speeds up a launch and lowers development cost. It also means the formula existed before you and may go to somebody else.

Korean manufacturers often quote the number of formulations they hold: five thousand, three thousand, so many since a given year. The figure reads as a measure of scale, and in part it is. But what matters more to a client is something else: which of those formulations will be offered to you personally, and on what terms.

What the library genuinely gives

Speed. A sample from an existing formulation takes days rather than months. On a three-month project that is the difference between making it and missing it.

Savings on development. You are not paying for laboratory work from scratch but for an adaptation, and that is a different order of money.

And, underrated, the absence of scale-up surprises. A formula already made in an industrial batch behaves predictably. A fresh development sometimes starts misbehaving exactly at the move from beaker to reactor.

What the library does not give

Exclusivity. The formulation existed before you, and by default nothing prevents it being offered to the next client. That is not deception: it is how the format works, and the price reflects it.

Uniqueness on the shelf. If your competitor works with the same factory, you may end up with the same product in different boxes. The consumer will not notice; a distributor notices quickly.

Three different offers that sound identical

The base formulation unchanged. Fastest and cheapest, no exclusivity.

The base with a modification: a different fragrance, a different texture, an adjusted share of an active. Dearer and slower, and exclusivity becomes a matter for the contract — sometimes your specific version is locked to you.

Development from scratch. Dearest and slowest, and only here can exclusivity be complete.

In correspondence all three are often called development. It is worth establishing which one is meant before discussing price.

What to ask the factory

Which of the three is being offered: the base, the base modified, or a new development.

Whether there is exclusivity, for how long and for which territory, and what happens when it ends.

Whether this formulation has been produced in an industrial batch, and how many times: that is the best answer to a question about stability.

Who owns the modification you have paid for.

And the lead time for a sample of this formulation — it shows how ready the library really is.